Barker Richard
a Centre for the Advancement of Sustainable Medical Innovation (CASMI) and Precision Medicine Catapult, University of Oxford , Oxford , UK.
Scand J Clin Lab Invest Suppl. 2016;245:S2-5. doi: 10.1080/00365513.2016.1206434. Epub 2016 Aug 17.
Precision medicine is now recognized globally as a major new era in medicine. It is being driven by advances in genomics and other 'omics' but also by the desire on the part of both health systems and governments to offer more targeted and cost-effective care. However, it faces a number of challenges, from the economics of developing more expensive companion diagnostics to the need to educate patients and the public on the advantages for them. New models of both R&D and care delivery are needed to capture the scientific, clinical and economic benefits of precision medicine.
精准医学如今在全球被公认为医学领域的一个重要新时代。它受到基因组学和其他“组学”进展的推动,同时也受到卫生系统和政府提供更具针对性和成本效益的医疗服务愿望的驱动。然而,它面临着诸多挑战,从开发更昂贵的伴随诊断的经济学问题到教育患者和公众了解其对他们的益处的必要性。需要新的研发和医疗服务模式来获取精准医学的科学、临床和经济效益。